Previously, the Jynneos monkeypox vaccine had been used in the U.S. only in clinical trials, Brett Petersen, MD, deputy chief of the CDC’s Poxvirus branch, confirmed to the newspaper.
The workers were in close contact with the male patient, who was hospitalized at Massachusetts General Hospital from May 12-20.
As of May 25, the CDC had identified nine monkeypox cases in seven states, according to CNN. The identified cases include the one in Massachusetts as well as cases in Florida, Utah, Washington, California, Virginia and New York.
In Boston, Massachusetts General Hospital officials separated potentially exposed workers into groups based on risk level, and as of May 26, fewer than 10 workers had been vaccinated, Paul Biddinger, MD, chief preparedness and continuity officer for Mass General Brigham, told the Globe.
Dr. Biddinger also called the effort “quite labor intensive,” telling the newspaper, “It took a huge number of people working all last week and through the weekend to make sure we could deliver the vaccines to those who wanted it and needed it.”
The vaccine the workers received is approved in adults 18 and older, according to the CDC. It is administered as two subcutaneous injections four weeks apart.
Read the full Globe report here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.